News

Updates on activities and accomplishments at AYOXXA

As a young and dynamic company determined to anticipate and respond to customer needs, we continue to achieve milestones, bring novel products to market, expand our partnerships, and explore use of our LUNARIS™ technology in new research areas. Follow these developments here.

Conferences

Meet AYOXXA

AYOXXA @ 14th Annual Biomarkers Congress 2019 in Manchester

AYOXXA introduces its innovative LUNARIS™ technology to senior level attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions, all working in the biomarker space across multiple therapeutic areas worldwide.

Read more

Meet AYOXXA

AYOXXA @ 37th Annual J.P. Morgan Healthcare Conference

AYOXXA introduces its innovative LUNARIS™ platform to executives from internationally renowned pharmaceutical and biotech companies as well as to members of the investment community, meeting at the largest and most informative healthcare investment symposium in the industry from January 7 - 10, 2019 at the Westin St. Francis Hotel in San Francisco, California.

Read more

Meet AYOXXA

AYOXXA @ the "iSearch", Basic Research in Ophthalmology Meeting

iSearch is a forum for basic experimental research in ophthalmology, where new findings about signaling pathways and pathomechanisms involving immune cells of the retina are presented.

Read more

Press Reviews

Press Review

Multi-cytokine profiles inform treatment decisions

Proteomics is an indispensable tool to elucidate disease etiology. Understanding the molecular background of a disease enables the development of more effective drugs and precise, reliable diagnostics.

Read more

Press Review

June Cover Story: Deep Tech

With AYOXXA cited as one of "the hottest Southeast Asian startups in Biotech", this article is telling the story of  co-founders Andreas Schmidt & Dieter Trau: From first conceptual ideas to groundbreaking technology platform and growing AYOXXA into a  young, innovative Biotech company.

Read more

Press Review

Translational proteomics at clinical scale

Proteomics is an indispensable methodology for advancing our understanding of disease etiology and the process of drug development, particularly in the post-genome era. Today, researchers often analyze entire protein networks and translate the knowledge generated from basic research into powerful clinical approaches in medical sciences. To fully explore this complex biology, enabling tools and technologies are vital.

Read more

Press Releases

Press Release

AYOXXA signs research agreement in the field of ophthalmology with one of the leading pharmaceutical companies

AYOXXA Biosystems GmbH, an international biotechnology company offering a range of products and services which enable advances in translational proteomics, today announced that it has signed a research agreement with one of the leading pharmaceutical companies for the development of a series of low volume, high sensitivity multiplex protein assays intend to validate protein biomarkers in the field of ophthalmology.

Read more

Press Release

AYOXXA launches LUNARIS™ Human & Mouse 6-Plex T Cell Characterization Kits to elucidate T cell differentiation

AYOXXA Biosystems GmbH, an international biotechnology company offering a range of products and services which enable advances in translational proteomics, today announced the expansion of its catalogue of kits for fully scalable multiplex protein analysis with the introduction of LUNARISTM Human & Mouse 6-Plex T Cell Characterization Kits.

Read more

Press Release

AYOXXA launches LUNARIS™ Human 12-Plex Th17 Kit expanding its portfolio for fully scalable biomarker analysis

AYOXXA Biosystems GmbH, an international biotechnology company offering a range of products and services which enable advances in translational proteomics, today announced the expansion of its catalogue of kits for fully scalable multiplex protein analysis with the introduction of LUNARISTM Human 12-Plex Th17 Kit for the quantitative validation of soluble pro-inflammatory T helper 17 (Th17) cell-related markers.

Read more

Contact

Get in touch with us to ask questions, get help, or discuss a project.

Gender

* The following fields are required for sending a request.

AYOXXA Newsletter

Be the first to know! Get regular news on AYOXXA and our products.

* The following fields are required for signing up our newsletter.

Connect with AYOXXA

Follow news and developments on these networks and platforms.